With the rise of biologics, sponsors are facing new challenges in how drugs are administered to patients. This is especially true in oncology studies, where intravenous infusion has become commonplace. Coupled with sites in remote areas of the world and a shift in responsibilities from sites to sponsors, the supply chain of ancillaries has never been more complex.
Download now and learn how to:
- Eliminate the need to determine unnecessary site-specific supplies
- Save months of work for all parties
- Increase flexibility in the supply chain